Crossref
Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?
AME Clinical Trials Review · 2026-04 · 4 · 14-14
DOI: 10.21037/actr-25-89 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Coyin Oh und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Oh, C., & Mahalingam, D. (2026). Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?. AME Clinical Trials Review, 4, 14-14. https://doi.org/10.21037/actr-25-89
Vancouver
Oh C, Mahalingam D. Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?. AME Clinical Trials Review. 2026;4:14-14. doi:10.21037/actr-25-89
BibTeX
@article{Oh2026,
author = {Oh, Coyin and Mahalingam, Devalingam},
title = {Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?},
journal = {AME Clinical Trials Review},
year = {2026},
volume = {4},
pages = {14--14},
doi = {10.21037/actr-25-89}
}
EUVIMED